Literature DB >> 8221518

Acrodermatitis chronica atrophicans.

E Asbrink1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8221518     DOI： 10.1016/0738-081x(93)90092-q

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN： 0738-081X            Impact factor:   3.541


× No keyword cloud information.
  6 in total

1.  Success and failure in the treatment of acrodermatitis chronica atrophicans.

Authors:  E Aberer; F Breier; G Stanek; B Schmidt
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

2.  Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis.

Authors:  M J Mathiesen; M Christiansen; K Hansen; A Holm; E Asbrink; M Theisen
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

Review 3.  Laboratory Diagnosis of Lyme Borreliosis.

Authors:  John A Branda; Allen C Steere
Journal:  Clin Microbiol Rev       Date:  2021-01-27       Impact factor: 26.132

4.  Acrodermatitis chronica atrophicans: clinical and microbiological characteristics of a cohort of 693 Slovenian patients.

Authors:  K Ogrinc; V Maraspin; L Lusa; T Cerar Kišek; E Ružić-Sabljić; F Strle
Journal:  J Intern Med       Date:  2021-03-13       Impact factor: 13.068

5.  Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society.

Authors:  Heidelore Hofmann; Volker Fingerle; Klaus-Peter Hunfeld; Hans-Iko Huppertz; Andreas Krause; Sebastian Rauer; Bernhard Ruf
Journal:  Ger Med Sci       Date:  2017-09-05

6.  Gender disparity between cutaneous and non-cutaneous manifestations of Lyme borreliosis.

Authors:  Franc Strle; Gary P Wormser; Paul Mead; Kanthi Dhaduvai; Michael V Longo; Omosalewa Adenikinju; Sandeep Soman; Yodit Tefera; Vera Maraspin; Stanka Lotrič-Furlan; Katarina Ogrinc; Jože Cimperman; Eva Ružić-Sabljić; Daša Stupica
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.